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SUMMARY AT A GLANCE
This study investigated response to pulmonary rehabilitation in subjects with IPF grouped according to the Medical Research Council (MRC) dyspnea scale. Compared to those with severe disability (MRC grades 4 and 5) who showed little or no benefit following rehabilitation, greater benefits occurred in MRC grade 2 and 3 subjects.
INTRODUCTION
Patients with IPF commonly report exertional dyspnea that leads to a decrease in exercise tolerance, limits their ability to perform activities of daily living (ADL) and results in impaired health-related quality of life (HRQoL). 1 Pulmonary rehabilitation, has been shown to improve dyspnea, exercise tolerance and HRQoL in patients with a variety of interstitial lung diseases (ILD), including IPF. 2, 3 However, in patients with IPF, the magnitude of improvement following rehabilitation tends to be more modest than that observed in individuals with other types of ILD, 4 and significantly less when compared to the benefits reported in patients with chronic obstructive pulmonary disease (COPD). 5 Further, any improvements seen in patients with IPF appear to be short-lived. 2, 5 Idiopathic pulmonary fibrosis is a heterogeneous disorder in terms of disease progression, response to therapy and prognosis. 6 Therefore, the optimal timing for pulmonary rehabilitation in the disease trajectory requires consideration. It is unclear whether the severity of IPF and the associated disability that arises due to exertional dyspnea affects the response to rehabilitation. We hypothesized that the baseline level of disability would influence the magnitude of response to pulmonary rehabilitation.
The aim of this study was to investigate whether there was a difference in the response to pulmonary rehabilitation in subjects with IPF grouped according to their disability level categorized using the Medical Research Council (MRC) (1 to 5) dyspnea scale.
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METHODS
Subjects
A prospective non-randomized, non-controlled study was undertaken. We recruited consecutive patients with a diagnosis of IPF based on the International Consensus Statement 6 who were referred to the pulmonary rehabilitation program (PRP) at Nagasaki University Hospital. Individuals were eligible to participate if they were under the care of a respiratory physician, ambulant, reported dyspnea on exertion and were clinically stable with no changes in medication for at least 4 weeks prior to recruitment.
Data from some subjects have contributed to previous work. 5, 8 Exclusion criteria were MRC grade 1, severe orthopedic or neurological disorders limiting exercise performance, unstable cardiac disease, active cancer, inability to complete questionnaires and previous participation in a PRP.
The Human Ethics Review Committee of Nagasaki University Graduate School of Biomedical Sciences approved this study. Subjects gave written, informed consent prior to data collection.
Measurements
The following variables were recorded at the time of recruitment to the study; BMI, time since diagnosis, use of long term oxygen therapy (LTOT) and oral corticosteroids, presence of cough, and right ventricular systolic pressure measured by transthoracic echocardiogram. Measures were obtained of spirometry and DL CO , 9, 10 and MRC grade was recorded during patient interview. Subjects in grades 2, 3 and 4 underwent an incremental cycle ergometry test (ICET) using methodology previously described. 8 The purpose of this test was to measure peak power to enable prescription of the initial intensity for lower limb endurance training.
Outcome Measures
The following measurements were completed at baseline and immediately following the ). The 6-minute walk test was performed twice, separated by 24 hours. 12 The best 6MWD was used in the analysis. Subjects who were receiving LTOT performed the test breathing oxygen supplied at their prescribed flow rate for daily activities. Oxygen saturation (SpO 2 , Konica Minolta Pulsox Me Oximeter and finger probe, Osaka, Japan) was monitored continuously throughout the test and the test was terminated if SpO 2 reached below 80%. 13 The lowest SpO 2 measured during or immediately post-test was recorded. The Borg category ratio scale 14 was used to measure dyspnea prior to and upon test completion. Heart rate was monitored continuously throughout the test using telemetry (Polar A1, Polar Electro, Oy, Finland).
Secondary outcome measures comprised dyspnea (Baseline and Transition Dyspnea
Indices, BDI/TDI 15 ), peripheral muscle force (quadriceps force, QF) and limitations in ADL. Quadriceps force was assessed during a maximum isometric quadriceps contraction using a hand-held dynamometer with fixing-belt (μTas F-1, Anima Corporation, Tokyo, Japan). Measurements were made on the dominant side and the highest value of three technically correct attempts was used in the analyses. Subjects rated their limitations in ADL using a standard scale. 16 This scale evaluates six activities (i.e. feeding, transfers, dressing, bathing, shopping, and transportation) and assigns a score of 1 (independent) or 0 (dependent) for each activity. The total score was used in the analysis.
Hospitalization
The number of hospital admissions and total bed-days (sum of bed-days from all admissions) in the 12-month period before and following the PRP were recorded. These data were collected by self report and verified by searching hospital databases.
Pulmonary Rehabilitation Program
Subjects in MRC grades 2, 3, and 4 attended an 8-week outpatient program comprising two sessions each week (90 minutes duration) during which they were individually supervised for the exercise training and, together with other subjects with IPF, participated in the education component of the program. This program has been described in detail elsewhere. 5 In brief, each session included exercise training, relaxation, breathing retraining (breathing control techniques aimed at reducing respiratory frequency) and education. The exercise component comprised endurance and strength training of the upper and lower limbs. Lower limb endurance training was performed using a cycle ergometer with the initial workload prescribed at 50% of the peak power achieved on the baseline ICET. Once subjects could achieve 20 min of continuous cycling, the workload was increased within symptom tolerance. The decision to provide a home-based program was made because of severe symptoms that restricted their ability to travel to the hospital to attend classes, and evidence of a high attrition from center-based PRP among patients with severe disability. 17 Exercise training comprised endurance and strength training similar to that prescribed for subjects in MRC grades 2, 3, and 4 with the exception that lower limb endurance exercise was confined to walking. Subjects were prescribed interval training (walk for 1 minute at 100% of the average walking speed achieved on the 6-minute walk test alternating with 1 minute of walking at 50% of this speed). A physiotherapist (RK) provided instruction in exercise and breathing retraining (breathing control techniques).
An education booklet was provided at the baseline assessment that covered the topics included in the out-patient program. In addition, the physiotherapist reviewed subjects every 2 weeks when they attended the hospital for consultation with their respiratory physician. At this time, subjects performed their exercise program in the presence of the physiotherapist and, where necessary, the exercise prescription and flow rate of supplemental oxygen were modified to ensure symptoms were tolerable and SpO 2 was maintained above 85%. During the 8 weeks, subjects were encouraged to undertake daily exercise and a physiotherapist made contact by phone twice each week to provide motivation and support, and to resolve any problems with the program.
For all subjects, adherence with the home exercise program was recorded using a diary card and medical therapy was unchanged during the PRP.
Data Management and Statistical Analysis
The Shapiro-Wilks test was used to examine the extent to which data approached a normal distribution. Data that did not conform to a normal distribution were transformed or were analyzed using non-parametric tests. Missing data were replaced by the last observation carried forward method. 18 Within group changes in the outcome measures following the PRP were compared using paired t tests or Wilcoxon signed rank test. Differences between groups (i.e. MRC grades) at baseline and the magnitude of change in outcome measures following rehabilitation were compared using a one-way analysis of variance (ANOVA) or Kruskal-Wallis test, and Chi-square test. For those variables showing a significant difference, Bonferroni adjustments were applied to post-hoc tests to account for multiple comparisons. Hospitalization data for the 12 months pre-and post-rehabilitation were compared using were compared using Chi-square test (number of subjects admitted to hospital and total number of admissions) and paired t-tests (total bed days) and Wilcoxon signed rank test (average length of stay). Data from individuals who did not survive the 12 months following the PRP were excluded from this analysis.
Data are expressed as means ± SD or 95% confidence intervals unless otherwise stated.
The significance level was set at P<0.05. All analyses were performed using SPSS software Version 17 (SPSS Inc, Chicago, Illinois, USA).
RESULTS
Subject Characteristics and Baseline Measures
The baseline characteristics of the subjects grouped by MRC grade are shown in Table 1 .
Six-minute walk distance, QF, ADL score and all subscales of the SF-36, with the exception of bodily pain, decreased with increasing MRC grade (all P<0.05).
Effects of the Rehabilitation Program
No adverse events were recorded during exercise training. Table 2 
Hospitalization
During the follow-up period, two subjects in grade 5 died. Table 3 shows the number of admissions and total bed-days for the remaining 63 subjects in the 12 months before and following rehabilitation. Subjects in MRC grades 2, 3 and 4 had less admissions following rehabilitation (all P<0.05).
DISCUSSION
In this study, we compared the response to pulmonary rehabilitation in IPF subjects grouped according to their severity of disability using the MRC dyspnea scale. While adherence with the PRP was similar irrespective of MRC grade, attrition tended to be greater in MRC grade 4 and 5 subjects, however, this difference was not significant possibly due to the small sample size. Most notably, the magnitude of benefit following rehabilitation varied depending on the baseline level of disability. In MRC grade 2 and 3 subjects, there were significant improvements in 6MWD, SF-36, QF and ADL score after the PRP. The magnitude of improvement in 6MWD in MRC grade 2 subjects and health status, in both MRC grade 2 and 3 subjects reached the thresholds for clinical significance. 19, 20 In contrast, subjects in grades 4 and 5 showed little or no improvement, or deteriorated. We also evaluated the effect of rehabilitation on hospitalization, and found that hospitalizations were reduced in the 12 months following rehabilitation for subjects in MRC grades 2, 3 and 4. To our knowledge, this is the first study investigating the effects of a PRP on outcomes that include hospitalizations in subjects with IPF.
The finding that subjects in MRC grade 5 show little benefit from rehabilitation is consistent with some 21, 22 but not all studies 23 in COPD subjects with severe disability.
However, in contrast to our findings, these studies [21] [22] [23] all reported improvements in MRC grade 4 subjects. There are several factors that may contribute to the lack of improvement following rehabilitation in IPF subjects in grades 4 and 5. The clinical course of patients with IPF is variable 24, 25 and the median survival is approximately 3 years from the time of diagnosis.
26-28
The MRC dyspnea grade is both a good indicator of disease severity and survival in IPF. 29 It is possible that rapid disease progression limited the capacity for benefits to be gained from rehabilitation in MRC grade 4 and 5 subjects. The increase in the length of stay for hospital admissions in the 12 months following rehabilitation in grade 5 subjects provides support for this contention and suggests that the clinical status of these patients was deteriorating rapidly. The problem of attempting to control severe dyspnea, cough and profound hypoxemia during exercise training may have resulted in a training intensity that was insufficient to achieve a physiologic effect. A high proportion of subjects in grades 4 (76%) and 5 (87%) were taking oral corticosteroids and it is possible that the effects of the training regimen were diluted by steroid-induced muscle abnormalities. 30, 31 Further, the program may have been too short to overcome the very poor physical fitness and muscle deconditioning that had occurred after a long period of reduced activity.
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Although possible, we consider it unlikely that the home-based setting and lower number of exercise sessions per week account for the lack of benefit in subjects in grade 5 given those in grade 4 also failed to show significant improvements in 6MWD, health status or quadriceps strength despite undergoing an out-patient program that demonstrated benefit in subjects with less severe disability (i.e. grades 2 and 3).
Ferreira et al 32 in a retrospective study, examined the effects of rehabilitation in 99 patients with ILD (50 with IPF). These authors reported an association between a lower baseline 6MWD and a greater magnitude of increase following rehabilitation. Our findings contrast with these observations. However, these authors did not state whether the patients were in a stable condition at the time of commencing the PRP. Therefore, deconditioning resulting from physical inactivity during a recent exacerbation may have contributed to this observation.
Pulmonary rehabilitation has been shown to reduce hospitalization in patients with COPD, [33] [34] [35] and it may be the result of improved muscle function, increased physical activity or changes in behavior or attitudes to disease management. [36] [37] [38] In grade 4 subjects, a decrease in hospitalization occurred in the absence of significant improvements in other outcome measures. The education sessions may have contributed to the reduction in hospitalization as a result of improved adherence with treatments and earlier recognition and management of exacerbations.
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Limitations
This study has several limitations that include the small sample size. We did not include a control group and thus are unable to account for confounding factors that may have affected both the outcomes measured immediately following the PRP and the hospitalization data. Further, due to the lack of a control group we are both unable to comment on whether a rapid rate of disease progression in MRC grade 4 and 5 subjects impacted on outcomes or whether the PRP had any effect on the rate of decline. We used the SF-36 because there are no disease-specific instruments to measure HRQoL in subjects with IPF. However, the SF-36 may lack sensitivity to demonstrate improvements in subjects with severe disability. Finally, we did not measure physical activity and therefore it is unknown whether changes in physical activity occurred following the PRP, and if such changes contributed to the reduction in hospitalization following rehabilitation.
Implications
The present findings suggest that patients with IPF should be referred for pulmonary 
